Fresenius Medical Care Sees U.S. Plans for Kidney Disease as Positive
As a health professional, you need the leading dialysis products, renal pharmaceuticals and critical care solutions. Let's work together to find you the tools you need, so you can deliver the best care for patients.
Power your practice with our resources. We're here to help support your patients and your thriving practice.
Every day, we’re working tirelessly to transform the future of healthcare. Because every patient deserves treatment as strong as they are.
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
We are actively monitoring the novel coronavirus (COVID-19) pandemic. Learn About the steps that we are taking to protect our patients, employees, physicians, and partners. If you are a patient with questions or concerns, please find additional information at FreseniusKidneyCare.com and AzuraVascularCare.com
Success! The link has been copied to your clipboard.
To celebrate Fresenius Medical Care North America’s merger with NxStage, a leader in home dialysis and critical care, more than 300 employees from both companies “canstructed” custom structures using 18,000 canned goods, later donating all products to the Greater Boston Food Bank.
With the recent merger, the company aims to give patients better access to new technology that is allowing more people with kidney failure to live fuller lives by dialyzing at home.
The six canned good structures included a set of three-dimensional kidneys, the companies’ logos and a house to demonstrate the focus on home dialysis treatment.
To learn more about the merger with NxStage, read this Q&A with CEOs Bill Valle and Jeff Burbank.